GELS Stock Chart & Stats
$0.70
$0.13(5.65%)
At close: 4:00 PM EST
$0.70
$0.13(5.65%)
Day’s Range― - ―
52-Week Range$0.39 - $2.02
Previous CloseN/A
Volume20.79K
Average Volume (3M)254.02K
Market Cap
$6.31M
Enterprise Value$18.77M
Total Cash (Recent Filing)$24.52K
Total Debt (Recent Filing)$3.84M
Price to Earnings (P/E)―
Beta2.73
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding10,711,059
10 Day Avg. Volume243,092
30 Day Avg. Volume254,018
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap2.98
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-19.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GELS FAQ
What was Gelteq Limited’s price range in the past 12 months?
Gelteq Limited lowest stock price was $0.39 and its highest was $2.02 in the past 12 months.
What is Gelteq Limited’s market cap?
Gelteq Limited’s market cap is $6.31M.
When is Gelteq Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Gelteq Limited’s earnings last quarter?
Currently, no data Available
Is Gelteq Limited overvalued?
According to Wall Street analysts Gelteq Limited’s price is currently Overvalued.
Does Gelteq Limited pay dividends?
Gelteq Limited does not currently pay dividends.
What is Gelteq Limited’s EPS estimate?
Gelteq Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelteq Limited have?
Gelteq Limited has 10,711,059 shares outstanding.
What happened to Gelteq Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Gelteq Limited?
Currently, no hedge funds are holding shares in GELS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Gelteq Limited
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Technical Analysis
China Pharma Holdings
―
Prophase Labs
―
Sunshine Biopharma
―
IM Cannabis Corp
―
Biofrontera
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.19% Other Institutional Investors
99.81% Public Companies and
Individual Investors








